|
|
|
| Clinical effect of Maiguan Fukang Capsules combined with Nimergoline in treating post-stroke cognitive impairment with syndrome of internal blockade of static blood |
| WU Xiaoping1 MA Long2 WU Wei3 SANG Yuanyuan1 LIANG Hai1 |
1.Department of Pharmacy, Bozhou People’s Hospital, Anhui Province, Bozhou 236800, China;
2.Department of Internal Neurology, Bozhou People’s Hospital, Anhui Province, Bozhou 236800, China;
3.Department of Endocrinology, Bozhou People’s Hospital, Anhui Province, Bozhou 236800, China
|
|
|
|
Abstract Objective To investigate the clinical effect of Maiguan Fukang Capsules combined with Nimergoline in treating post-stroke cognitive impairment (PSCI) with syndrome of internal blockade of static blood. Methods A total of 86 patients with PSCI with syndrome of internal blockade of static blood admitted to Bozhou People’s Hospital of Anhui Province from January 2021 to July 2022 were selected and divided into control group (43 cases) and observation group (43 cases) according to the random number table method. The control group was treated with Nimergoline, and the observation group was treated with Maiguan Fukang Capsules combined with Nimergoline. The two groups were treated for eight weeks. The clinical efficacy was compared between two groups, traditional Chinese medicine syndrome score, mini-mental state examination (MMSE) score, National Institutes of Health stroke scale (NIHSS) score, cerebral blood flow velocity, serum neuron specific enolase (NSE), superoxide dismutase (SOD), and malondialdehyde (MDA) were compared between the two groups before and after treatment, and the safety was evaluated. Results The curative effect of the observation group was better than that of the control group (P＜0.05). After treatment, the traditional Chinese medicine syndrome score, NIHSS score, and levels of NSE and MDA of the two groups were lower than those before treatment, and the MMSE score, SOD level, and blood flow velocity of left middle cerebral artery (LMCA), left posterior cerebral artery (LPCA), right posterior cerebral artery (RPCA) were higher than those before treatment, the traditional Chinese medicine syndrome score, NIHSS score, and levels of NSE and MDA of the observation group were lower than those of the control group, and the MMSE score, SOD level, and blood flow velocity of LMCA, LPCA, RPCA were higher than those of the control group (P＜0.05). No obvious adverse reactions occurred in the two groups during the treatment. Conclusion Maiguan Fukang Capsules combined with Nimergoline has a significant effect in the treatment of PSCI with syndrome of internal blockade of static blood, which can effectively improve cognitive impairment, neuronal damage, and cerebral blood flow, reduce oxidative stress response, and has high safety.
|
|
|
|
|
|
[1] 《中国脑卒中防治报告》编写组.《中国脑卒中防治报告2020》概要[J].中国脑血管病杂志，2022，19（2）：136-144.
[2] 汪凯，董强.卒中后认知障碍管理专家共识2021[J].中国卒中杂志，2021，16（4）：376-389.
[3] 中国卒中学会卒中后认知障碍研究圆桌会议专家组.中国卒中后认知障碍防治研究专家共识[J].中国卒中杂志，2020，15（2）：158-166.
[4] 杨丽超，李银萍，杨蓉.尼麦角林联合降纤酶治疗短暂性脑缺血发作的临床研究[J].现代药物与临床，2020，35（1）：65-69.
[5] 李俊，胡小军，王青，等.通窍活血汤加减联合“回阳九针”治疗卒中后认知障碍的临床观察[J].中国实验方剂学杂志，2019，25（4）：75-80.
[6] 杨珊莉，蔡素芳，吴静怡，等.中西医结合康复临床实践指南·认知障碍[J].康复学报，2020，30（5）：343-348.
[7] 何道胜，周会，李良勇，等.脉管复康胶囊辅助治疗急性脑梗死的临床效果[J].中国医药导报，2022，19（14）：60- 64.
[8] 方之勇，于军平.脉管复康胶囊治疗恢复期气虚血瘀型脑卒中的临床效果及对患者肢体功能恢复的作用[J].中国医药，2021，16（6）：849-852.
[9] 郑筱萸.中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002：90-99.
[10] 史悦，高小夏，谈笑，等.中文版认知障碍简要测试量表与简易精神状态检查量表在脑卒中患者认知评估中的比较分析[J].重庆医科大学学报，2021，46（11）：1310- 1314.
[11] 张本银，路吾长，杨靖.美国国立卫生研究院卒中量表评分、血浆同型半胱氨酸水平与急性脑梗死的关系及危险因素分析[J].实用临床医药杂志，2021，25（22）：102-105.
[12] 杨帆，李兴义，满劲进，等.卒中后认知障碍早期预测因素的研究进展[J].神经损伤与功能重建，2022，17（4）：218-221.
[13] 张君琴，张国新，张振涛.急性缺血性脑卒中后认知障碍的危险因素分析[J].中风与神经疾病杂志，2021，38（1）：32-35.
[14] 赵万年，焦胜先，焦倩，等.中国人群卒中后认知障碍发生危险因素的Meta分析[J].疑难病杂志，2023，22（1）：82-89.
[15] 李艳，辜刚凤，王建.卒中后认知障碍的研究进展[J].中国实用神经疾病杂志，2022，25（5）：647-651.
[16] 代瑞兰，温晓妮，李芳，等.脑卒中后认知障碍的机制[J].中国老年学杂志，2020，40（7）：1558-1561.
[17] 陈璐菡，陈伟良.尼麦角林联合阿替普酶治疗对急性缺血性脑卒中患者Chemerin、miR-128b表达的影响[J].广东医学，2022，43（5）：613-617.
[18] 黄攀，何晓英，徐敏.尼麦角林联合盐酸多奈哌齐治疗阿尔茨海默病的单中心临床研究[J].中国老年学杂志，2022，42（3）：611-614.
[19] 许济，李花，田苗，等.脑卒中后认知功能障碍发生率及其危险因素分析[J].安徽医药，2021，25（2）：321-325.
[20] 李丽博，苑振云，刘静，等.脑血流动力学改变与脑小血管病发生发展关系的研究进展[J].山东医药，2021，61（27）：89-93.
[21] 步霄，贾师捷，周叶，等.急性缺血性脑卒中患者血清CRP、TNF-α、IL-1β、HIF-1α、NSE、SAA对神经功能损伤的诊断价值[J].广东医学，2021，42（1）：90-95.
[22] 左洪州，褚堃，唐玲，等.脑卒中后认知障碍血液学生物标志物的研究进展[J].中华神经医学杂志，2021，20（4）：412-416.
[23] 朱紫衣，李毓龙，李阳超，等.氧化应激在缺血性脑卒中中的作用研究进展[J].广西医学，2021，43（21）：2605- 2608.
[24] 凌佳，张宗奇，李清华，等.治疗血管性认知障碍的中药有效成分研究进展[J].临床内科杂志，2021，38（11）：734-737.
[25] 孙毅红，白雨朦，王艳国，等.鸡血藤提取物改善睡眠剥夺诱导的学习认知功能障碍的作用[J].包头医学院学报，2022，38（8）：1-8.
[26] 林凯莉，张世卿.去甲氧基姜黄素通过促进海马神经发生对阿尔兹海默症认知损伤的改善作用[J].中成药，2022，44（8）：2476-2482. |
|
|
|
